CEO Jarle Bruun and CTO Peter W. Eide are back on the Radium podcast with an update on Oncosyne’s progress. They discuss early data from the company’s diagnostic test, which is identifying potentially effective drugs for patients in the ongoing randomized study at Akershus University Hospital, led by Professor Anne Hansen Ree, where patients are now receiving treatment guided by the platform.
The conversation also covers new clinical collaborations with Sahlgrenska University Hospital, the University of Oslo, and Skåne University Hospital, extending the work into harder-to-treat GI cancers including pancreatic, gastric, and esophageal cancer, alongside the company’s growth and ongoing funding round.
Listen to the episode here.
https://open.spotify.com/episode/4EaIgJXUMh6F81WiEs2hFZ?si=CbhjsYnYT82_D4B6WXP-yw&nd=1&dlsi=839bd1df01454055
